Immunology and Microbiology
Plasmodium falciparum
74%
Gene
46%
Plasmodium vivax
46%
Vaccine Efficacy
45%
Monospecific Antibody
39%
Sample
39%
Parasite
38%
Dengue Fever
34%
Antigen
32%
Development
20%
Time
19%
Prevalence
19%
Blood Plasma
18%
Mosquito
15%
Viral Disease
15%
Human Immunodeficiency Virus 1
14%
Dengue Virus
14%
Human
13%
Genetic Variability
12%
Erythrocyte
11%
Liver
11%
Parasitemia
11%
Chloroquine
11%
Monoclonal Antibody
11%
Immunogenicity
10%
Serotype
10%
Polymerase Chain Reaction
9%
Antimicrobial Resistance
9%
Gametocyte
9%
Enzyme-Linked Immunosorbent Assay
9%
Hemocyte
9%
Extract
8%
ELISA
8%
Surface Property
8%
Haplotype
7%
Allele
7%
Fever
7%
Neutralizing Antibody
7%
Real-Time Polymerase Chain Reaction
7%
Drug Resistance
7%
Virulence
6%
Dengue Vaccine
6%
Bacteriophage
6%
Coinfection
6%
Immunoglobulin M
6%
Apoptosis
6%
Biofilm
6%
Aptitude
6%
Animal
6%
Allergen
6%
Macrophage
6%
Larva
6%
Western Blot
5%
Reticulocyte
5%
Cytokine
5%
Influenza
5%
Tissues
5%
Epitope
5%
Mutant
5%
Polymerase Chain Reaction
5%
Wild Type
5%
Immunity
5%
Membrane
5%
Kidney
5%
HIV Vaccine
5%
Sporozoite
5%
Clone
5%
Chikungunya Virus
5%
Medicine and Dentistry
Patient
100%
Melioidosis
41%
Malaria
39%
Disease
36%
Therapeutic Procedure
36%
Diagnosis
34%
Adult
23%
Hospital
22%
Analysis
22%
Dengue Fever
20%
Child
20%
Inpatient
18%
Vaccine
16%
Evaluation Study
16%
Woman
13%
Serum
13%
COVID-19
12%
Malaria Falciparum
12%
Health
12%
Parasite (Microbiology)
12%
Culture
12%
Weil's Disease
11%
Incidence
11%
Cohort Effect
10%
Traveler
10%
Systematic Review
10%
Mortality
10%
Male
9%
Case Report
9%
Blood
9%
Fever
9%
Enzyme Linked Immunosorbent Assay
9%
Antibiotic Resistance
9%
Plasmodium Vivax Malaria
8%
Symptoms
8%
Age
8%
Plasmodium
8%
Meta-Analysis
8%
Sepsis
8%
Pathogen
8%
Public Health
7%
Tuberculosis
7%
Observational Study
7%
Antibiotics
7%
Odds Ratio
7%
Antibody
6%
Cross Sectional Study
6%
Drug
6%
Laboratory
6%
Female
6%
Scrub Typhus
6%
Liver
6%
Men Who Have Sex with Men
6%
Health Care Cost
6%
Dengue Virus
6%
Pneumonia
6%
Follow up
6%
In Vitro
6%
Biological Marker
5%
Refugee
5%
Severe Acute Respiratory Syndrome Coronavirus 2
5%
Placebo
5%
Human
5%
Serotype
5%
Acute Kidney Injury
5%
Cohort Analysis
5%
Human Immunodeficiency Virus Vaccine
5%
Virus Infection
5%
Blood Culture
5%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
36%
Diseases
31%
Dengue
29%
Plasmodium falciparum
26%
Melioidosis
22%
Artesunate
19%
Artemisinin
17%
Elimination
17%
HIV
14%
Protein
13%
Mefloquine
11%
Dihydroartemisinin
11%
Chloroquine
10%
Piperaquine
10%
Antiinfective Agent
10%
Antibiotics
8%
Antimicrobial Resistance
7%
Pharmacokinetics
7%
Coronavirinae
7%
Clinical Trial
7%
Combination Therapy
6%
Parasitemia
6%
Blindness
6%
Immunogenicity
6%
Artemether Plus Benflumetol
5%
Drug Administration
5%
Enzyme-Linked Immunosorbent Assay
5%
Cohort Study
5%
Antibiotic Agent
5%
Randomized Controlled Trial
5%
Epidemiology
5%
Sepsis
5%
Antioxidant
5%
Peptide
5%
Diabetes Mellitus
5%